Sally Ross

Company: iTeos Therapeutics
Job title: Project Head
Seminars:
Can Biomarkers Be Used to Identify Patients Who Are Most Likely to Benefit from Adenosine-Pathway Targeted Cancer Immunotherapy? 12:10 pm
• Discussing the role of adenosine in the tumor microenvironment • Divulging biomarkers as surrogates for the presence of adenosine • Highlighting the A2AR as a biomarker for response to inupadenant in iTeos clinical trialsRead more
day: Day One